رجوع
85
مُدرج أيضًا باسم
HMDCF
OTC
نطاق اليوم
KWD 13.84
KWD 14.12
نطاق 52 أسبوعًا
KWD 11.51
KWD 19.50
حجم التداول
16,136
متوسط 50 يوم / 200 يوم
KWD 14.74
/
KWD 15.33
الإغلاق السابق
KWD 14.00
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 5.6 | 0.3 |
| P/B | 2.1 | 2.9 |
| ROE % | 45.9 | 3.7 |
| Net Margin % | 83.3 | 3.8 |
| Rev Growth 5Y % | 11.5 | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 17.500
+23.9%
مكرر الربحية المستقبلي
44.1
ربحية السهم المستقبلية
KWD 0.317
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
640 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.170
KWD 1.087 – KWD 1.352
|
1.2 B | 1 |
| FY2029 |
KWD 0.885
KWD 0.822 – KWD 1.022
|
1.1 B | 1 |
| FY2028 |
KWD 0.599
KWD 0.557 – KWD 0.692
|
840 M | 1 |
النقاط الرئيسية
Revenue grew 11.48% annually over 5 years — strong growth
Earnings grew 1114.23% over the past year
ROE of 45.86% indicates high profitability
Net margin of 83.30% shows strong profitability
Debt/Equity of 0.08 — conservative balance sheet
Negative free cash flow of -79.01M
النمو
Revenue Growth (5Y)
11.48%
Revenue (1Y)-12.73%
Earnings (1Y)1114.23%
FCF Growth (3Y)N/A
الجودة
Return on Equity
45.86%
ROIC-3.07%
Net Margin83.30%
Op. Margin-9.95%
الأمان
Debt / Equity
0.08
Current Ratio4.96
Interest Coverage-19.05
التقييم
P/E Ratio
5.57
P/B Ratio2.06
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -12.73% | Revenue Growth (3Y) | -18.99% |
| Earnings Growth (1Y) | 1114.23% | Earnings Growth (3Y) | 113.21% |
| Revenue Growth (5Y) | 11.48% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 549.96M | Net Income (TTM) | 458.12M |
| ROE | 45.86% | ROA | 26.13% |
| Gross Margin | 38.68% | Operating Margin | -9.95% |
| Net Margin | 83.30% | Free Cash Flow (TTM) | -79.01M |
| ROIC | -3.07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.08 | Current Ratio | 4.96 |
| Interest Coverage | -19.05 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 5.57 | P/B Ratio | 2.06 |
| P/S Ratio | 4.64 | PEG Ratio | 0.00 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.55B | Enterprise Value | 2.58B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 549.96M | 630.20M | 838.00M | 426.41M | 356.13M |
| Net Income | 458.12M | 37.73M | 100.78M | -360.84M | -194.65M |
| EPS (Diluted) | 2.60 | 0.22 | 0.60 | -2.15 | -1.25 |
| Gross Profit | 212.72M | 281.32M | 453.55M | 115.31M | 97.89M |
| Operating Income | -54.73M | -43.71M | 18.38M | -409.77M | -344.29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.75B | 1.27B | 1.28B | 1.03B | 1.37B |
| Total Liabilities | 501.84M | 502.34M | 536.39M | 392.58M | 333.15M |
| Shareholders' Equity | 1.24B | 759.93M | 730.54M | 610.37M | 986.89M |
| Total Debt | 97.89M | 89.82M | 86.13M | 27.01M | 38.98M |
| Cash & Equivalents | 71.33M | 153.96M | 283.59M | 313.28M | 377.54M |
| Current Assets | 1.57B | 1.07B | 1.10B | 839.89M | 1.21B |
| Current Liabilities | 315.78M | 376.56M | 403.03M | 353.90M | 311.66M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#20 of 670
النشاط الأخير
دخل
Contrarian Investing (David Dreman)
Mar 24, 2026